Sjöholm B - Search Results

1

Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.

Koulu M, Lappalainen J, Hietala J, Sjöholm B. Koulu M, et al. Among authors: sjoholm b. Psychopharmacology (Berl). 1990;101(2):168-71. doi: 10.1007/BF02244121. Psychopharmacology (Berl). 1990. PMID: 2140903

2

Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.

Lappalainen J, Hietala J, Koulu M, Sjöholm B, Syvälahti E. Lappalainen J, et al. Among authors: sjoholm b. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(6):861-72. doi: 10.1016/0278-5846(91)90014-r. Prog Neuropsychopharmacol Biol Psychiatry. 1991. PMID: 1722342

3

Hypothalamic monoamines and food intake in alcohol-preferring AA and alcohol-avoiding ANA rats.

Korpi ER, Päivärinta P, Sjöholm B, Koulu M. Korpi ER, et al. Among authors: sjoholm b. Alcohol. 1991 Mar-Apr;8(2):137-41. doi: 10.1016/0741-8329(91)91322-s. Alcohol. 1991. PMID: 1829611

4

Effects of chronic SCH 23390 treatment on dopamine autoreceptor function in rat brain.

Lappalainen J, Hietala J, Sjöholm B, Syvälahti E. Lappalainen J, et al. Among authors: sjoholm b. Eur J Pharmacol. 1990 Apr 25;179(3):315-21. doi: 10.1016/0014-2999(90)90171-2. Eur J Pharmacol. 1990. PMID: 1973105

5

5-HT3 receptor antagonist ondansetron does not alter effects of amphetamine on DA metabolism.

Koulu M, Lappalainen J, Hietala J, Sjöholm B, Virtanen R. Koulu M, et al. Among authors: sjoholm b. Neuroreport. 1990 Oct;1(2):126-8. doi: 10.1097/00001756-199010000-00011. Neuroreport. 1990. PMID: 2151795

6

Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.

Lappalainen J, Hietala J, Koulu M, Seppälä T, Sjöholm B, Syvälahti E. Lappalainen J, et al. Among authors: sjoholm b. J Pharmacol Exp Ther. 1990 Feb;252(2):845-52. J Pharmacol Exp Ther. 1990. PMID: 2179533

7

Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.

Koulu M, Sjöholm B, Lappalainen J, Virtanen R. Koulu M, et al. Among authors: sjoholm b. Eur J Pharmacol. 1989 Oct 10;169(2-3):321-4. doi: 10.1016/0014-2999(89)90031-9. Eur J Pharmacol. 1989. PMID: 2530097

8

Characterization of [3H]atipamezole as a radioligand for alpha 2-adrenoceptors.

Sjöholm B, Voutilainen R, Luomala K, Savola JM, Scheinin M. Sjöholm B, et al. Eur J Pharmacol. 1992 Apr 29;215(1):109-17. doi: 10.1016/0014-2999(92)90615-b. Eur J Pharmacol. 1992. PMID: 1355439

9

Nonadrenergic binding of [3H]atipamezole in rat lung. A novel imidazole binding site?

Sjöholm B, Savola JM, Scheinin M. Sjöholm B, et al. Ann N Y Acad Sci. 1995 Jul 12;763:66-77. doi: 10.1111/j.1749-6632.1995.tb32391.x. Ann N Y Acad Sci. 1995. PMID: 7677386 No abstract available.

10

Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist.

Sallinen J, Link RE, Haapalinna A, Viitamaa T, Kulatunga M, Sjöholm B, Macdonald E, Pelto-Huikko M, Leino T, Barsh GS, Kobilka BK, Scheinin M. Sallinen J, et al. Among authors: sjoholm b. Mol Pharmacol. 1997 Jan;51(1):36-46. doi: 10.1124/mol.51.1.36. Mol Pharmacol. 1997. PMID: 9016344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters